Insight into the etiopathogenesis of obesity and lymphedema in SPG11 may not only extend current knowledge on the mechanism of SPG11-linked neurodegeneration but also provide novel targets to interfere with the metabolic phenotype. This evidence concerns the gene SPG11 and obesity due to melanocortin 4 receptor deficiency.